Seagen

US FTC seeks additional info on Pfizer's proposed takeover of Seagen

The deal for Pfizer will add four approved cancer therapies with combined sales of nearly US$2 billion in 2022.

Pfizer signs US$43 billion Seagen deal in cancer drug push